Role of gamma interferon in cellular immune response against murine Encephalitozoon cuniculi infection

Infection and Immunity

Volumn 67, Issue 4, 1999, Pages 1887-1893

  Khan, Imtiaz A ^a   Moretto, Magali ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2;

ANIMAL EXPERIMENT; ARTICLE; ENCEPHALITOZOON; HOST RESISTANCE; INFECTION PREVENTION; INFECTION RESISTANCE; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION; T LYMPHOCYTE ACTIVATION;

EID: 0033003532     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.4.1887-1893.1999     Document Type: Article

References (54)

1. Achbarou, A., C. Ombrouck, T. Gneragbe, F. Charlotte, L. Renia, I. Desportes-Livage, and D. Mazier. 1916. Experimental model for human intestinal microsporidiosis in interferon gamma receptor knockout mice infected by Encephalitozoon intestinales. Parasite Immunol. 18:387-392.
2. Belich, M. P., R. J. Glynne, G. Senger, D. Sheer, and J. Trowsdale. 1994. Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins. Curr. Biol. 4:769-776.
3. Candolfi, E., C. A. Hunter, and J. S. Remington. 1995. Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferate response to concanavalin A and toxoplasma antigen during acute toxoplasmosis. Infect. Immun. 63:751-756.
4. Canning, E., and J. Lom. 1986. The microsporidia of vertebrates. Academic Press, New York, N.Y.
5. Coyle, C. M., M. Wittner, D. P. Kotler, C. Noyer, J. M. Orenstein, H. B. Tanowitz, and L. M. Weiss. 1996. Prevalence of microsporidiosis due to Enterocytozoon bieneusi and Encephalitozoon (Septata) intestinales among patients with AIDS-relaled diarrhea: determination by polymerase chain reaction to the microsporidian small-subunit rRNA gene. Clin. Infect. Dis. 23:1002-1006.
6. De Groote, M. A., G. Visvesvara, M. L. Wilson, N. J. Pieniazek, S. B. Slemenda, A. J. daSilva, G. J. Leitch, R. T. Bryan, and R. Reves. 1995. Polymerase chain reaction and culture confirmation of disseminated Encephalitozoon cuniculi in a patient with AIDS: successful therapy with albendazole. J. Infect. Dis. 171:1375-1378.
7. Denkers, E. Y., T. Scharton-Kersten, S. Barbieri, P. Caspar, and A. Sher. 1996. A role for CD4+ NK1.1+ T lymphocytes as major histocompatihility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection. J. Exp. Med. 184:131-139.
8. Deplazes, P., A. Mathis, R. Baumgartner, I. Tanner, and R. Weber. 1996. Immunologic and molecular characteristics of Encephalitozoon-like microsporidia isolated from humans and rabbits indicate that Encephalitozoon cuniculi is a zoonotic parasite. Clin. Infect. Dis. 22:557-559.
9. Didier, E. S. 1995. Reactive nitrogen intermediates implicated in the inhibition of Encephalitozoon cuniculi (phylum Microspora) replication in murine peritoneal macrophages. Parasite Immunol. 17:405-412.
10. Didier, E. S., P. J. Didier, D. N. Friedberg, S. M. Stenson, J. M. Orenstein, R. W. Yee, F. O. Tio, R. M. Davis, C. Vossbrinck, N. Millichamp, et al. 1991. Isolation and characterization of a new human microsporidian. Encephalitozoon hellem (n. sp.), from three AIDS patients with keratoconjunctivitis. J. Infect. Dis. 163:617-621.
11. Didier, E. S., and J. A. Shadduck. 1988. Modulated immune responsiveness associated with experimental Encephalitozoon cuniculi infection in BALB/c mice. Lab. Anim. Sci. 38:680-684.
12. El Fakhry, Y., A. Achbarou, I. Desportes-Livage, and D. Mazier. 1998. Encephalitozoon intestinalis: humoral responses in interferon-gamma receptor knockout mice infected with a microsporidium pathogenic in AIDS patients. Exp. Parasitol. 89:113-121.
13. Green, L. C., D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126:131-138.
14. Green, S. J., C. A. Nacy, and M. S. Meltzer. 1991. Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. J. Leukoc. Biol. 50:93-103.
15. Gregory, S. H., E. J. Wing, R. A. Hoffman, and R. L. Simmons. 1993. Reactive nitrogen intermediates suppress the primary immunologic response to Listeria. J. Immunol. 150:2901-2909.
16. Gunsegaran, K., C. J. H., S. Mahalingam, C. F. Nathan, and J. D. MacMicking. 1998. Rapid interferon-γ-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase2-deficient mice. J. Exp. Med. 188:1541-1546.
17. Haque, S., I. Khan, A. Haque, and L. Kasper. 1994. Impairment of the cellular immune response in acute murine toxoplasmosis: regulation of interleukin-2 production and macrophage-mediated inhibitory effects. Infect. Immun. 62:2908-2916.
18. Hermanek, J., B. Koudela, Z. Kucerova, O. Ditrich, and J. Travnicek. 1993. Prophylactic and therapeutic immune reconstitution of SCID mice infected with Encephalitozoon cuniculi. Folia Parasitol. 40:287-291.
19. Hollister, W. S., E. U. Canning, N. I. Colbourn, and E. J. Aarons. 1995. Encephalitozoon cuniculi isolated from the urine of an AIDS patient, which differs from canine and murine isolates. J. Eukaryot. Microbiol. 42:367-372.
20. Igietseme, J. U. 1996. Molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide in vivo. Immunology 88:1-5.
21. James, S. L., A. W. Cheever, P. Caspar, and T. A. Wynn. 1998. Inducible nitric oxide synthase-deficient mice develop enhanced type 1 cytokine-associated cellular and humoral responses after vaccination with attenuated Schistosoma mansoni cercariae but display partially reduced resistance. Infect. Immun. 66:3510-3518.
22. Khan, I. A., T. Matsuura, and L. H. Kasper. 1995. IL-10 mediates immunosuppression following primary infection with Toxoplasma gondii in mice. Parasite Immunol. 17:185-195.
23. Khan, I. A., T. Matsuura, and L. H. Kasper. 1998. Inducible nitric oxide synthase is not required for long term vaccine based immunity against Toxoplasma gondii. J. Immunol. 161:2994-3000.
24. Khan, I. A., J. D. Schwartzman, S. Fonseka, and L. H. Kasper. 1997. Neospora caninum: role for immune cytokines in host immunity. Exp. Parasitol. 85:24-34.
25. Khan, I. A., J. D. Schwartzman, T. Matsuura, and L. H. Kasper. 1997. A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc. Natl. Acad. Sci. USA 94:13955-13960.
26. Koudela, B., J. Vitovec, Z. Kucerova, O. Ditrich, and J. Travnicek. 1993. The severe combined immunodeficient mouse as a model for Encephalitozoon cuniculi microsporidiosis. Folia Parasitol. 40:279-286.
27. Kreil, T. R., and M. M. Eibl. 1996. Nitric oxide and viral infection: NO antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo. Virology 219:304-306.
28. Launois, P., J. A. Louis, and G. Milon. 1997. The fate and persistence of Leishmania major in mice of different genetic backgrounds: an example of exploitation of the immune system by intracellular parasites. Parasitology 115:S25-S32.
29. Locksley, R. M., S. L. Reiner, F. Hatam, D. R. Littman, and N. Killeen. 1993. Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science 261:1448-1451.
30. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C. Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4:471-481.
31. Mattsson, R., A. Mattsson, R. Holmdahl, A. Scheynius, and P. H. Van der Meide. 1992. In vivo treatment with interferon-gamma during early pregnancy in mice induces strong expression of major histocompatibility complex class I and II molecules in uterus and decidua but not in extra-embryonic tissues. Biol. Reprod. 46:1176-1186.
32. McCabe, R. E., B. J. Luft, and J. S. Remington. 1984. Effect of murine interferon gamma on murine toxoplasmosis. J. Infect. Dis. 150:961-962.
33. McLeod, R., P. Eisenhauer, D. Mack, C. Brown, G. Filice, and G. Spitalny. 1989. Immune responses associated with early survival after peroral infection with Toxoplasma gondii. J. Immunol. 142:3247-3255.
34. Neter, J., W. Wasserman, and M. H. Kuter. 1985. Applied linear statistical models. Irwin, Homewood, Ill.
35. Niederkorn, J. Y., J. A. Shadduck, and E. C. Schmidt. 1981. Susceptibility of selected inbred strains of mice to Encephalitozoon cuniculi. J. Infect. Dis. 144:249-253.
36. Reiner, S. L., S. Zheng, D. B. Corry, and R. M. Locksley. 1993. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods 165:37-46. (Errata, 173:133 and 175:275, 1994.)
37. Roach, T. I., C. H. Barton, D. Chatterjee, F. Y. Liew, and J. M. Blackwell. 1995. Opposing effects of interferon-gamma on iNOS and interleukin-10 expression in lipopolysaccharide- and mycobacterial lipoarabinomannan-stimulated macrophages. Immunology 85:106-113.
38. Rockett, K. A, M. M. Awburn, E. J. Rockett, W. B. Cowden, and I. A. Clark. 1994. Possible role of nitric oxide in malarial immunosuppression. Parasite Immunol. 16:243-249.
39. Scharton-Kersten, T. M., G. Yap, J. Magram, and A. Sher. 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185:1261-1273.
40. Schmidt, E. C., and J. A. Shadduck. 1984. Mechanisms of resistance to the intracellular protozoan Encephalitozoon cuniculi in mice. J. Immunol. 133: 2712-2719.
41. Schmidt, E. C., and J. A. Shadduck. 1983. Murine encephalitozoonosis model for studying the host-parasite relationship of a chronic infection. Infect. Immun. 40:936-942.
42. Schwacha, M. G., and T. K. Eisenstein. 1997. Interleukin-12 is critical for induction of nitric oxide-mediated immunosuppression following vaccination of mice with attenuated Salmonella typhimurium. Infect. Immun. 65:4897-4903.
43. Shadduck, J. A. 1969. Nosema cuiculi: in vitro isolation. Science 166:516-517.
44. Shadduck, J. A., and E. Greeley. 1989. Microsporidia and human infections. Clin. Microbiol. Rev. 2:158-165.
45. Sharma, D. P., A. J. Ramsay, D. J. Maguire, M. S. Rolph, and I. A. Ramshaw. 1996. Enterleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J. Virol. 70:7103-7107.
46. Sternberg, J., and F. McGuigan. 1992. Nitric oxide mediates suppression of T cell responses in murine Trypanosoma bruceii infection. Eur. J. Immunol. 22:2741-2744.
47. Suzuki, Y., F. K. Conley, and J. S. Remington. 1989. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. J. Immunol. 143:2045-2050.
48. Utermohlen, O., A. Dangel, A. Tarnok, and F. Lehmann-Grube. 1996. Modulation by gamma interferon of antiviral cell-mediated immune responses in vivo. J. Virol. 70:1521-1526.
49. Von Herrath, M. G., B. Coon, and M. B. Oldstone. 1997. Low-affinity cytotoxic T-lymphocytcs require IFN-gamma to clear an acute viral infection. Virology 229:349-359.
50. Weber, R., P. Deplazes, M. Flepp, A. Mathis, R. Baumann, B. Sauer, H. Kuster, and R. Luthy. 1997. Cerebral microsporidiosis due to Encephalitozoon cuniculi in a patient with human immunodeficiency virus infection. N. Engl. J. Med. 336:474-478.
51. Wittner, M., H. B. Tanowitz, and L. M. Weiss. 1993. Parasitic infections in AIDS patients. Cryptosporidiosis, isosporiasis, microsporidiosis, cyclosporiasis. Infect. Dis. Clin. North Am. 7:569-586.
52. Woods, M. L. D., J. Mayer, T. G. Evans, and J. B. Hibbs, Jr. 1994. Antiparasitic effects of nitric oxide in an in vitro murine model of Chlamydia trachomatis infection and an in vivo murine model of Leishmania major infection. Immunol. Ser. 60:179-195.
53. Yang, J., and M. Mitsuyama. 1997. An essential role for endogenous interferon-gamma in the generation of protective T cells against Mycobacterium bovis BCG in mice. Immunology 91:529-535.
54. Zender, H. O., E. Arrigoni, J. Eckert, and Y. Kapanci. 1989. A case of Encephalitozoon cuniculi peritonitis in a patient with AIDS. Am. J. Clin. Pathol. 92:352-356.